A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
Explore this paper's citation graph
Summary
This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.
- Type
- article
- Published
- 2014-08-07
- Cited by
- 1,123
- References
- 53
- Access
- Open access
- OpenAlex
- https://openalex.org/W2119361626
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:17722399
Keywords
Medicine, Hypertrophic cardiomyopathy, Cardiology, Internal medicine, Implantable cardioverter-defibrillator
References
- Clinical prediction models: are we building better mousetraps?
- Prognosis and prognostic research: application and impact of prognostic models in clinical practice
- Sudden cardiac death in hypertrophic cardiomyopathy.
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
- An evaluation of penalised survival methods for developing prognostic models with rare events
- Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
- Concordance probability and discriminatory power in proportional hazards regression
- Partial residuals for the proportional hazards regression model
- Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
- Clinical Prediction Models: A Practical Approach to Development, Validation and Updating
- Prognosis and prognostic research: what, why, and how?
- Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
- Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
- Trastornos graves de la conducción cardiaca e implante de marcapasos en pacientes con miocardiopatía hipertrófica
- Predictors of sudden cardiac death in hypertrophic cardiomyopathy.
- Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
- Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates.
- Clinical Prediction Models—a Practical Approach to Development, Validation and Updating
- Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration.
- Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy.
Cited by
- Recommendations for the diagnosis and management of hypertrophic cardiomyopathy in 2014.
- Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
- Significance and Determinants of Cardiac Troponin I in Patients With Obstructive Hypertrophic Cardiomyopathy.
- Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.
- Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy.
- Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy
- Clinicopathological and Genetic Profiles of Cases with Myocyte Disarray—Investigation for Establishing the Autopsy Diagnostic Criteria for Hypertrophic Cardiomyopathy
- The Structural Determinants and Functional Consequences of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
- Comentarios a la guía de práctica clínica de la ESC 2014 sobre el diagnóstico y manejo de la miocardiopatía hipertrófica. Una vision crítica desde la cardiología española
- Cardiovascular Genetics and Genomics
- ICD-Therapie zur Primär- und Sekundärprophylaxe kongenitaler arrhythmogener Erkrankungen
- Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
- [Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy].
- A Systematic Review of Phenotypic Features Associated With Cardiac Troponin I Mutations in Hereditary Cardiomyopathies.
- ICD-Therapie zur Primärprävention des plötzlichen Herztodes
- Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy
- ESC-Leitlinie 2014 zur Diagnose und zum Management der hypertrophischen Kardiomyopathie
- Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
- The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data
- The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Related papers
- [Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy].
- Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
- Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy
- Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort ― Results From the Kochi RYOMA Study ―
- Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.
- Advances of cardiovascular MRI in hypertrophic cardiomyopathy.
- Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD
- O28-2 - ESC Recommended HCM Risk-SCD Model May Not Be Applicable to Japanese Patients with Hypertrophic Cardiomyopathy to Predict Sudden Cardiac Death